Orient Europharma Co Ltd (4120) — Free Cash Flow Generation Index
Orient Europharma Co Ltd (4120) has a Free Cash Flow Generation Index of -1.68x as of June 2025. Free cash flow of NT$-55.78 Million represents -2% of operating cash flow (NT$33.25 Million). Explore Orient Europharma Co Ltd (4120) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Orient Europharma Co Ltd Free Cash Flow Generation Index (2015–2023)
Historical FCF Generation Index trend for Orient Europharma Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see 4120 cash generation efficiency.
Annual Free Cash Flow Generation for Orient Europharma Co Ltd (2015–2023)
Year-by-year Free Cash Flow Generation Index for Orient Europharma Co Ltd. Check cash flow reinvestment rate of Orient Europharma Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.56x | NT$-36.03 Million | NT$64.67 Million | NT$100.70 Million | ▲ +97.1% |
| 2021 | -19.19x | NT$-1.49 Billion | NT$77.65 Million | NT$1.56 Billion | ▼ -3227.5% |
| 2020 | 0.61x | NT$373.43 Million | NT$608.55 Million | NT$232.78 Million | ▲ +186.6% |
| 2019 | 0.21x | NT$48.68 Million | NT$227.37 Million | NT$124.98 Million | ▲ +84.2% |
| 2018 | 0.12x | NT$26.88 Million | NT$231.31 Million | NT$201.61 Million | ▼ -80.8% |
| 2017 | 0.61x | NT$364.28 Million | NT$601.08 Million | NT$367.66 Million | ▼ -79.9% |
| 2016 | 3.02x | NT$336.05 Million | NT$111.24 Million | NT$224.81 Million | ▲ +122.7% |
| 2015 | 1.36x | NT$873.51 Million | NT$643.97 Million | NT$229.54 Million | — |